Genesis CancerCare and Trans-Tasman Radiation Oncology Group Strategic Partnership
The Trans-Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research working with over nine hundred researchers and doctors in more than 50 trials involving over 12,000 patient volunteers to help advance cancer treatments. GenesisCare is the leading provider of radiation oncology in Australia undertaking around 320,000 cancer treatments every year and is currently involved in over 40 clinical trials.
GenesisCare and TROG will work together to improve patient access to clinical trials and promote innovation in research to deliver better patient outcomes.
Bupa Member Benefits
Genesis HeartCare, shares a long partnership with Bupa. As a member, you will be part of a program that aims to improve clinical outcomes for patients with cardiovascular disease. It also guarantees no out-of-pocket expenses for services from Genesis HeartCare cardiologists when you're admitted into hospital. Click here for more information about this partnership.
|Genesis HeartCare - Clinical Outcomes & Quality Indicators||Download|